Chemoinformaics analysis of Crocetin monogentibiosyl ester
| Molecular Weight | 414.718 | nRot | 5 |
| Heavy Atom Molecular Weight | 364.318 | nRig | 22 |
| Exact Molecular Weight | 414.386 | nRing | 5 |
| Solubility: LogS | -6.993 | nHRing | 0 |
| Solubility: LogP | 7.243 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 82.5716 |
| nHD | 1 | BPOL | 50.1604 |
| QED | 0.485 |
| Synth | 5.383 |
| Natural Product Likeliness | 3.207 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.948 |
| MDCK | 0.000015 |
| BBB | 0.486 |
| PPB | 0.98334 |
| VDSS | 1.551 |
| FU | 0.0184161 |
| CYP1A2-inh | 0.027 |
| CYP1A2-sub | 0.402 |
| CYP2c19-inh | 0.071 |
| CYP2c19-sub | 0.96 |
| CYP2c9-inh | 0.085 |
| CYP2c9-sub | 0.444 |
| CYP2d6-inh | 0.034 |
| CYP2d6-sub | 0.302 |
| CYP3a4-inh | 0.296 |
| CYP3a4-sub | 0.497 |
| CL | 17.543 |
| T12 | 0.013 |
| hERG | 0.169 |
| Ames | 0.075 |
| ROA | 0.122 |
| SkinSen | 0.909 |
| Carcinogencity | 0.027 |
| EI | 0.019 |
| Respiratory | 0.867 |
| NR-Aromatase | 0.226 |
| Antiviral | No |
| Prediction | 0.638121 |